Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Pfizer tops earnings estimates, hikes full-year guidance as Covid products help sales
Pfizer tops earnings estimates, hikes full-year guidance as Covid products help sales
Pfizer tops earnings estimates, hikes full-year guidance as Covid products help sales
Submitted by
admin
on October 29, 2024 - 11:47am
Source:
CNBC
News Tags:
Pfizer
earnings
COVID-19
Starboard Value
Headline:
Pfizer tops earnings estimates, hikes full-year guidance as Covid products help sales
snippet:
Pfizer reported third-quarter revenue and adjusted profit that blew past expectations.
The company hiked its full-year outlook as its Covid vaccine and antiviral pill Paxlovid helped boost sales.
It is a critical quarterly report for Pfizer, which is grappling with activist pressure from Starboard Value.
Do Not Allow Advertisers to Use My Personal information
